Dr. Jack Feldman

I should say, the Spearman-G factor starts at a particular level in the population

at age 20 and declines about 1% a year.

So sorry to say, we're not 20-year-olds anymore.

But when you get a number from that, you can put on the curve and see whether it's about your age or not.

These people were about 10 years older according to that metric.

And long story short, after three months, this is a placebo-controlled double-blind study.

The people who were in the placebo arm improved two years, which is common for human studies because of placebo effect.

The people who got the compound improved eight years on average.

And some improved more than eight years.

They didn't do any further diagnosis as to what caused the myocardial decline.

But it was pretty, it was extraordinarily impressive.

It's in the paper, and it's basically what they have in the compound, which is sold commercially.

So the compound, which is sold commercially, is handled by a nutraceutical wholesaler who sells it to the retailers, and they make whatever formulation they want.

But it's a dosage which is, my understanding, is rarely tolerable.

I take half a dose.

The reason I take half a dose is that I had my blood magnesium measured.

And it was low normal for my age.

I took half a dose.

It became high normal.

And I felt comfortable staying in the normal range.